Typing of Pseudomonas aeruginosa strains in Turkish cystic fibrosis patients

New Microbiologica

Volumn 26, Issue 1, 2003, Pages 109-114

  Yagci, A ^a   Ciragil, P ^b   Over, U ^a   Sener, B ^c   Erturan, Z ^d   Soyletir, G ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antimicrobial susceptibility; AP PCR; Cystic fibrosis; Pseudomonas aeruginosa; Virulence factors

Indexed keywords

ALGINIC ACID; ALKALINE PROTEINASE; AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; PENEM DERIVATIVE; QUINOLONE DERIVATIVE; VIRULENCE FACTOR; BACTERIAL DNA; BACTERIAL PROTEIN; METALLOPROTEINASE; PSEUDOLYSIN, PSEUDOMONAS AERUGINOSA; SERRALYSIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; CROSS INFECTION; CYSTIC FIBROSIS; GENOTYPE; HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; TURKEY (REPUBLIC); CHEMISTRY; CLASSIFICATION; ENZYMOLOGY; GENETICS; GRAM NEGATIVE INFECTION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; VIRULENCE;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

ALGINATES; BACTERIAL PROTEINS; CYSTIC FIBROSIS; DNA, BACTERIAL; HUMANS; METALLOENDOPEPTIDASES; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TURKEY; VIRULENCE;

EID: 0037270776     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BURKE, V., ROBINSON, J., RICHARDSON, J., and BUNDEL, C. (1991). Longitudinal studies of virulence factors of Pseudomonas aeruginosa in cystic fibrosis. Pathology, 23, 145-148.
2. CIMOLAI, N., and TROMBLEY, C. (1996). Enterobacterial intergenic consensus sequnce polymerase chain reaction as a typing method for Burkholderia (Pseudomonas) cepacia. Clinica Microbiology and Infection, 2, 59-62.
3. CYSTIC FIBROSIS FOUNDATION (1997). Cystic Fibrosis Foundation Patient Registry 1996 Annual Data Report. Bethesda, Md: Cystic Fibrosis Foundation.
4. DA SILVA FILHO, L.V., LEVI, J.E., BENTO, C.N., RODRIGUES, J.C., and DA SILVO RAMOS, S.R. (2000). Molecular epidemiology of Pseudomonas aeruginosa infections in a cystic fibrosis outpatient clinic. Journal Medical of Microbiology, 50, 261-267.
5. DURING, G., CONWAY, S., ÖEIJERMAN, H., HODSON, M., HOIBY, N., SYMITH, A., TOUW, D., FOR THE CONSENSUS COMMITTEE (2000). Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. European Respiratory Journal, 16, 749-767.
6. FEGAN, M., FRANCIS, P., HAYWARD, C., and FUERS, J. (1991). Heterogeneity, persistance and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients. Journal of Clinical Microbiology, 29, 2151-2157.
7. FLUGE, G., OJENIYI, B., HOIBY, N., DIGRANES, A., CIOFU, O., HUNSTAD, E., HAANES, O.C., and STORROSTEN, O.T. (2000). Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clinical Microbiology and Infection, 7, 238.
8. GIARDANO, A., MAGNI, A., GRAZIANI, C., SESSA, R., QUATTRUCCI, S., and CIPRIANI, P. (2000). AP-PCR typing of Pseudomonas aeruginosa isolated from cystic fibrosis. New Microbiologica, 24, 157-163.
9. KERNACKI, K.A., HOBDEN, J.A., HAZLETI, L.D., FRIDMAN, R., and BERK, R.S. (1996). In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Investigative Ophthalmology and Visual Science, 37, 1371-80.
10. MAHENTHIRALINGAM, E., CAMPBELL, M., FOSTER, J., LAM, J., and SPEERT, D. (1999). Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. Journal of Clinical Microbiology, 34, 1129-1135.
11. MAY, T., and CHAKRABARTY, A.M. (1994). Isolation and assay of Pseudomonas aeruginosa alginate. Enzymology, 235, 295-304.
12. NATIONAL COMMITTE FOR CLINICAL LABORATORY STANDARTS (2000). Dilution procedures for susceptibility testing of anaerobic bacteria. Approved standard NCCLS Publication M7A5, Pennsylvania.
13. OJENIYI, B., FREDERIKSEN, B., and HOIBY, N. (2000). Pseudomonas aeruginosa cross- infection among patients with cystic fibrosis during a winter camp. Pediatric Pulmonology, 29, 177-181.
14. PEDERSEN, S., HOIBY, N., ESPERSEN, F., and KOCH, C. (1992). Role of alginate in infection with mucoid P. aeruginosa in cystic fibrosis. Thorax, 47, 6-13.
15. RENDERS, N., VAN BELKUM, A., BARTH, A., MOUTON, J., and VERBURGH, H. (1996). Typing of Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotyping versus genotyping. Clinical Microbiology and Infection, 1, 261-265
16. ROMLING, U., FIEDLER, B., BOBHAMMER, J., GROTHUES, D., GREIPEL, J., VON DER HARDT, H., and TUMMLER, B. (1994). Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. Journal of Infectious Diseases, 170, 1616-1621.
17. RUST, L., MESSING, R.C., and IGLEWSKI, B.H. (1994). Elastase assays. Methods in Enzymology, 235, 554-562.
18. SLAYERS, A., and WHIT, D. (1994). Pseudomonas aeruginosa. In Slayers, A., Whit, D. (eds). Bacterial pathogenesis. A molecular approach. Washington. ASM Press 260- 270.
19. WILLIAMS, T. (1997). Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross- infection at a cystic fibrosis patients. British Journal of Biomedical Science, 54, 181-185.